Annual Statement of Changes in Beneficial Ownership (5)
January 23 2020 - 4:53PM
Edgar (US Regulatory)
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ]
Form 3 Holdings Reported
[ ]
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0362
Estimated average burden hours per response...
1.0
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
STANGER KENT W | 2. Issuer Name and Ticker or Trading SymbolMERIT MEDICAL SYSTEMS INC [MMSI] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
1600 W MERIT PARKWAY | 3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) 12/31/2019 |
(Street)
SOUTH JORDAN, UT 84095
(City)
(State)
(Zip)
| 4. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any | 3. Trans. Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) |
Amount | (A) or (D) | Price |
Common Stock, No Par Value | | | | | | | 42278 | I | By 401(k) plan (1) |
Common Stock, No Par Value | | | | | | | 4271 (2) | D | |
Common Stock, No Par Value | | | | | | | 29524 | I | Family Limited Liability Company (3) |
Common Stock, No Par Value | 10/30/2019 | | G (4) | 2769 | D | $0 | 412318 | D | |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (MM/DD/YYYY) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
(A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Non-qualified stock options (right to buy) | $12.06 | | | | | | 10/4/2015 (5) | 10/4/2021 | Common Stock | 2000 | | 2000 | D | |
Non-qualified stock options (right to buy) | $19.72 | | | | | | 5/2/2017 (6) | 5/2/2023 | Common Stock | 9375 | | 9375 | D | |
Non-qualified stock options (right to buy) | $18.80 | | | | | | 5/26/2017 (7) | 5/26/2023 | Common Stock | 25000 | | 25000 | D | |
Non-qualified stock options (right to buy) | $34.4 | | | | | | 5/24/2018 (8) | 5/24/2024 | Common Stock | 25000 | | 25000 | D | |
Non-qualified stock options (right to buy) | $50.5 | | | | | | 6/7/2019 (9) | 6/7/2025 | Common Stock | 25000 | | 25000 | D | |
Non-qualified stock options (right to buy) | $52.17 | | | | | | 5/24/2020 (10) | 5/24/2026 | Common Stock | 13750 | | 13750 | D | |
Non-qualified stock options (right to buy) | $52.17 | | | | | | 5/31/2020 (11) | 5/31/2026 | Common Stock | 7500 | | 7500 | D | |
Explanation of Responses: |
(1) | Represents plan holdings as of 01/22/2020. |
(2) | Employee stock purchase plan holdings as of 01/22/2020. |
(3) | This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC. |
(4) | This is a gift. |
(5) | Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. |
(6) | Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017. |
(7) | Becomes exercisable in equal annual installments of 20% commencing on 05/26/2017. |
(8) | Becomes exercisable in equal annual installments of 20% commencing on 05/24/2018. |
(9) | Becomes exercisable in equal annual installments of 20% commencing on 06/07/2019. |
(10) | Becomes exercisable in equal annual installments of 33% commencing on 05/24/2020. |
(11) | Becomes exercisable in equal annual installments of 33% commencing on 05/31/2020. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
STANGER KENT W 1600 W MERIT PARKWAY SOUTH JORDAN, UT 84095 | X |
|
|
|
Signatures
|
Brian G. Lloyd, Attorney-in-Fact | | 1/23/2020 |
**Signature of Reporting Person | Date |
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Apr 2023 to Apr 2024